Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

An extension of a Phase 3 trial assessing the combination of vildagliptin with metformin for Type 2 diabetes has been updated; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin) (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED